Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$667M |
| 3 |
Spotify
SPOT
|
+$528M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$438M |
| 5 |
Eli Lilly
LLY
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.59B |
| 2 |
Amazon
AMZN
|
+$1.45B |
| 3 |
Merck
MRK
|
+$925M |
| 4 |
Broadcom
AVGO
|
+$765M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$672M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.89% |
| 2 | Technology | 8.59% |
| 3 | Healthcare | 7.29% |
| 4 | Financials | 7.2% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
L3Harris
LHX
$48.9B
| $2.21M | ﹤0.01% |
+9,300
| New | +$2.15M |
|
3502
NCR Atleos
NATL
$3.42B
| $2.21M | ﹤0.01% |
77,490
-238,439
| -75% | -$6.94M |
|
3503
CALL
Tenet Healthcare
THC
$21.5B
| $2.21M | ﹤0.01% |
13,300
-5,700
| -30% | -$862K |
|
3504
PUT
Murphy Oil
MUR
$5.11B
| $2.21M | ﹤0.01% |
65,400
| – | – |
|
3505
Lexicon Pharmaceuticals
LXRX
$1.02B
| $2.2M | ﹤0.01% |
1,398,876
+801,555
| +134% | +$1.43M |
|
3506
CALL
Kinross Gold
KGC
$37.1B
| $2.2M | ﹤0.01% |
+234,600
| New | +$2.11M |
|
3507
iShares MSCI USA Value Factor ETF
VLUE
$9.77B
| $2.19M | ﹤0.01% |
20,110
+1,236
| +7% | +$130K |
|
3508
Encore Capital Group
ECPG
$2.1B
| $2.19M | ﹤0.01% |
46,370
-33,800
| -42% | -$1.6M |
|
3509
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $2.19M | ﹤0.01% |
12,231
-131,565
| -91% | -$22.5M |
|
|
IGMS
3510
DELISTED
IGM Biosciences
IGMS
| $2.19M | ﹤0.01% |
132,342
-258,871
| -66% | -$2.84M |
|
3511
CALL
Scorpio Tankers
STNG
$3.91B
| $2.19M | ﹤0.01% |
30,700
-1,700
| -5% | -$124K |
|
3512
CALL
Omnicell
OMCL
$1.51B
| $2.19M | ﹤0.01% |
50,200
+40,200
| +402% | +$1.51M |
|
3513
CALL
Henry Schein
HSIC
$9.98B
| $2.19M | ﹤0.01% |
+30,000
| New | +$2.08M |
|
3514
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.6B
| $2.18M | ﹤0.01% |
+64,753
| New | +$2.15M |
|
3515
XBiotech
XBIT
$69.2M
| $2.17M | ﹤0.01% |
281,019
-80,642
| -22% | -$530K |
|
|
GTM
3516
CALL
ZoomInfo Technologies
GTM
$1.22B
| $2.17M | ﹤0.01% |
210,000
+96,500
| +85% | +$1.01M |
|
3517
Horizon Technology Finance
HRZN
$315M
| $2.17M | ﹤0.01% |
+203,424
| New | +$2.33M |
|
3518
PUT
BHP
BHP
$242B
| $2.16M | ﹤0.01% |
34,700
+21,500
| +163% | +$1.19M |
|
3519
PUT
Neurocrine Biosciences
NBIX
$15.7B
| $2.15M | ﹤0.01% |
+18,700
| New | +$2.56M |
|
3520
PUT
CBRE Group
CBRE
$43.7B
| $2.15M | ﹤0.01% |
17,300
+7,800
| +82% | +$850K |
|
3521
CION Investment
CION
$363M
| $2.15M | ﹤0.01% |
180,892
-40,990
| -18% | -$495K |
|
3522
Vanguard Morningstar Value ETF
VTV
$192B
| $2.15M | ﹤0.01% |
12,322
-31,036
| -72% | -$5.2M |
|
3523
FIGS
FIGS
$2.56B
| $2.15M | ﹤0.01% |
313,747
-309,789
| -50% | -$1.81M |
|
3524
FirstService
FSV
$6.18B
| $2.14M | ﹤0.01% |
11,747
-197,550
| -94% | -$34M |
|
|
AKRO
3525
DELISTED
Akero Therapeutics
AKRO
| $2.14M | ﹤0.01% |
74,628
-94,963
| -56% | -$2.48M |
|
Similar funds
Israel Englander's Q3 2024 Portfolio in Review
As of Q3 2024, Israel Englander held 6,698 positions worth $211B, down 2.3% from $216B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander withdrew a net $16.9B in Q3 2024, closing 667 positions and reducing 2,445 holdings. Its most notable exit was WestRock Company, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Israel Englander opened a new position in Smurfit Westrock worth $94.1M.
- Israel Englander's largest Q3 2024 buy was Smurfit Westrock: 1,904,931 shares worth $94.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $1.38B increase.
- Israel Englander's biggest Q3 2024 reduction was Apple, cutting an estimated $2.59B.
- Israel Englander fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- Israel Englander's ten largest holdings make up 17% of its $211B portfolio in Q3 2024.
- Israel Englander opened 898 new positions and closed 667 in Q3 2024.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $211B.
Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.